West Pharmaceutical Services Inc. closed 44.51% short of its 52-week high of $396.75, which the company achieved on April 8th ...
Evercore ISI analyst Daniel Markowitz notes that West Pharmaceutical (WST) shares are down 30% since the company reported Q4 results, but ...
Thrivent Financial for Lutherans Sells 8,115 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
Thrivent Financial for Lutherans reduced its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report ...
With Q4 behind us, let’s have a look at West Pharmaceutical Services (NYSE:WST) and its peers. Companies specializing in drug development inputs and services play a crucial role in the ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
NEW YORK, NY / ACCESS Newswire / April 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West ...
As you can see from the chart above the percentage of shares that are sold short for West Pharmaceutical Servs has grown since its last report. This does not mean that the stock is going to fall ...
West Pharmaceutical Services has a 12-month low of $197.01 and a 12-month high of $397.72. The company has a current ratio of 2.79, a quick ratio of 2.23 and a debt-to-equity ratio of 0.08.
This was the stock's second consecutive day of losses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results